PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPraziquantel
Praziquantel
Praziquantel (praziquantel) is a small molecule pharmaceutical. Praziquantel was first approved as Biltricide on 1982-12-29. It is used to treat clonorchiasis, cysticercosis, helminthiasis, opisthorchiasis, and parasitic intestinal diseases amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
Trade Name
FDA
EMA
Praziquantel (discontinued: Biltricide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Praziquantel
Tradename
Company
Number
Date
Products
BILTRICIDEBayerN-018714 DISCN1982-12-29
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
biltricideNew Drug Application2023-12-06
praziquantelANDA2024-02-28
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
schistosomiasisEFO_1001475D012552B65
cysticercosisEFO_0007231D003551B69
helminthiasisEFO_1001342D006373B65-B83
parasitic intestinal diseasesEFO_0009561D007411B82
opisthorchiasisEFO_0007404D009889B66.0
clonorchiasisEFO_0007210D003003B66.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P02: Anthelmintics
— P02B: Antitrematodals
— P02BA: Quinoline derivatives and related substances, antitrematodals
— P02BA01: Praziquantel
HCPCS
No data
Clinical
Clinical Trials
56 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FilariasisD005368—B741————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePraziquantel
INNpraziquantel
Description
2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one is a member of isoquinolines.
Classification
Small molecule
Drug classanthelmintics (undefined group): 2-deoxoparaherquamide A derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1
Identifiers
PDB—
CAS-ID55268-74-1
RxCUI—
ChEMBL IDCHEMBL976
ChEBI ID—
PubChem CID4891
DrugBankDB01058
UNII ID6490C9U457 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Praziquantel
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,609 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
196 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use